Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004
Delusional State Following Acute Stroke
Neurol 62:110-113, Kumral,E. & Ozturk,O., 2004
Guillain-Barre Syndrome Seen in Users of Isotretinoin
BMJ 328:1537, Pritchard,J.,et al, 2004
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004
Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection
Arch Neurol 61:1523-1527, Alvarez-Lafuente,R.,et al, 2004
Risk Factors for Intracardiac Thrombus in Patients with Recent Ischaemic Cerebrovascular Events
JNNP 75:1421-1425, Sen,S.,et al, 2004
Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004
Diffusion-Weighted MRI in 300 Patients Presenting Late With Subacute Transient Ischemic Attack or Minor Stroke
Stroke 35:2459-2465, Schulz,U.G.,et al, 2004
The Occurence of Guillain-Barre Syndrome Within Families
Neurol 63:1747-1750, Geleijns,K.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004
Guillain-Barre Syndrome Follwoing Influenza Vaccination
JAMA 292:2478-2481, Haber,P.,et al, 2004
Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Relationships Between Angiographic Findings and National Institutes of Health Stroke Scale Score in Cases of Hyperacute Carotid Ischemic Stroke
AJNR 25:238-241, Nakajima,M.,et al, 2004
Acute Facial Diplegia and Hyperreflexia
Neurol 62:825-827, Susuki,K.,et al, 2004
Susac Syndrome:Report of Four Cases and Review of the Literature
AJNR 25:382-388,351, Do,T.H.,et al, 2004
Variants and Mimics of Guillain Barre Syndrome
The Neurologist 10:61-74, Levin,K.H., 2004
Acute Motor Axonal Neuropathy after Mycoplasma Infection,Evidence of Molecular Mimicry
Neurol 62:949-956, Susuki,K.,et al, 2004
Stroke Patterns, Etiology, and Prognosis in Patients with Diabetes Mellitus
Neurol 62:1558-1562, Karapanayiotides,Th.,et al, 2004
Infarct Patterns in Atherosclerotic Middle Cerebral Artery Versus Internal Carotid Artery Disease
Neurol 62:1291-1296, Lee,P.H.,et al, 2004
A Paralysed Thumb
Lancet 363:1364, Sudo,K.,et al, 2004
Diffusion-Weighted Magnetic Resonance Imaging in Internal Carotid Artery Dissection
Arch Neurol 61:510-512, Koch,S.,et al, 2004
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Strokes in the Subinsular Territory
Neurol 63:2429-2432, Kumral,E.,et al, 2004
Diffusion-weighted MRI in Cortical Ischaemia
Neuroradiol 46:175-182, Lovblad, K.O,et al, 2004
Cortical Laminar Necrosis in Brain Infarcts: Serial MRI
Neuroradiology 45:283-288, Siskas, N.,et al, 2003
Spinal Dural Arteriovenous Fistulas: Clinical Features in 80 Patients
JNNP 74:1438-1440, Jellema,K.,et al, 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
Emergency Intubation for Respiratory Failure in Guillain-Barre Syndrome
Arch Neurol 60:947-948, Wijdicks,E.F.M.,et al, 2003
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003
Multiple Sclerosis Presenting as Lower Motor Neuron Wasting and Weakness of the Distal Upper Extremity
Neurol 61:1303-1304, Chong,P.S.T.,et al, 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
Von Recklinghausen's Neurofibromatosis: Neurofibromatosis Type 1
Lancet 361:1552-1554, Reynolds,R.M., et al, 2003
Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003
Primary Lateral Sclerosis
Neurol 60:1258-1265, Zhai,P.,et al, 2003
Pure Dysarthria Due to Small Cortical Stroke
Neurol 60:1178-1180, Kim,J.S.,et al, 2003
Clinicopath Conf., Penumococcal penumonia with Endocarditis and Endophtlhalmitis
NEJM 348:834-842, Case 7-2003, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
The Impact of Delays in Computed Tomography of the Brain on the Accuracy of Diagnosis and Subsequent Management in Patients with Minor Stroke
JNNP 74:77-81, Wardlaw,J.M.,et al, 2003
The Morbidity of Guillain-Barre Syndrome Admitted to the Intensive Care Unit
Neurol 60:17-21, Henderson,R.D.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003
Association of Ischemic Lesion Patterns on Early Diffusion-Weighted Imaging with TOAST Stroke Subtypes
Arch Neurol 60:1730-1734, Kang,D.,et al, 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
Stroke Location, Characterization, Severity, and Outcome in Mitral vs Aortic Valve Endocarditis
Neurol 61:1341-1346, Anderson,D.J.,et al, 2003